Now showing items 1-2 of 2

    • A Wolf in Sheep's Clothing: Systemic Immune Activation Post Immunotherapy. 

      Tiu, C; Shinde, R; Pal, A; Biondo, A; Lee, A; et al. (Innovative Healthcare Institute, 2021-11-01)
      INTRODUCTION: Immune checkpoint inhibitors (ICIs) are increasingly a standard of care for many cancers; these agents can result in immune-related adverse events (irAEs) including fever, which is common but can rarely be ...
    • Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. 

      Guo, C; Sharp, A; Gurel, B; Crespo, M; Figueiredo, I; et al. (NATURE PORTFOLIO, 2023-11-30)
      Inflammation is a hallmark of cancer1. In patients with cancer, peripheral blood myeloid expansion, indicated by a high neutrophil-to-lymphocyte ratio, associates with shorter survival and treatment resistance across ...